An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and claims of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Worries
However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Some professionals said the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations.
Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Removal
According to TikTok, the service has taken down violative material and prohibited related hashtags and query recommendations. The organization stated it was committed to keeping the platform secure and investing in enhancing enforcement strategies.
Online Marketplace Operations
Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or injecting at residence.
After moments of joining one group, a seller shared WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Item Details and Costs
Inside these groups, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to possibly significant medical dangers”.
